Overview

Intravenous Metoprolol in Septic Shock

Status:
COMPLETED
Trial end date:
2024-11-10
Target enrollment:
Participant gender:
Summary
A RCT designed to assess the effect of giving intravenous beta-blockers in patients with septic shock after achieving hemodynamic stability. The principle of this study is to control heart rate allowing for better diastolic filling and thus better perfusion.
Phase:
PHASE2
Details
Lead Sponsor:
Alexandria University
Treatments:
Standard of Care